Romaine C Nichols Jr
Overview
Explore the profile of Romaine C Nichols Jr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
84
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chhabra A, Amos R, Simone 2nd C, Simone C, Kaiser A, Perles L, et al.
Int J Radiat Oncol Biol Phys
. 2025 Jan;
PMID: 39761799
Radiation therapy manages pancreatic cancer in various settings; however, the proximity of gastrointestinal (GI) luminal organs at risk (OARs) poses challenges to conventional radiation therapy. Proton beam therapy (PBT) may...
2.
Hotca A, Sindhu K, Lehrer E, Hartsell W, Vargas C, Tsai H, et al.
Adv Radiat Oncol
. 2024 Apr;
9(5):101459.
PMID: 38596455
Purpose: Treatment options for recurrent esophageal cancer (EC) previously treated with radiation therapy (RT) are limited. Reirradiation (reRT) with proton beam therapy (PBT) can offer lower toxicities by limiting doses...
3.
Rutenberg M, Hoppe B, Starr J, Awad Z, Thomas M, Morris C, et al.
Int J Part Ther
. 2023 Feb;
9(3):18-29.
PMID: 36721483
Purpose: When treating esophageal cancer with radiation therapy, it is critical to limit the dose to surrounding structures, such as the lung and/or heart, as much as possible. Proton radiation...
4.
Padgett M, Kharod S, Mercado C, Morris C, Rutenberg M, Nichols Jr R
J Gastrointest Oncol
. 2022 Jul;
13(3):1081-1085.
PMID: 35837158
Background: To compare patterns-of-care and clinical outcomes among uninsured versus insured patients (IPs) with anorectal malignancies referred for radiotherapy at an urban safety-net hospital. This topic is important because uninsured...
5.
Mendenhall W, Brooks E, Smith S, Morris C, Bryant C, Henderson R, et al.
Int J Part Ther
. 2022 Feb;
8(3):36-42.
PMID: 35127974
Purpose: To determine factors that influence insurance approval for definitive proton therapy (PT) for prostate cancer. Materials And Methods: Between 2014 and 2018, 1592 insured patients with localized prostate cancer...
6.
Zhu H, Nichols Jr R, Henderson R, Morris C, Pham D, Jones L, et al.
Acta Oncol
. 2017 Nov;
57(5):692-693.
PMID: 29103341
No abstract available.
7.
Nichols Jr R, Huh S, Henderson R, Li Z, Flampouri S, DAgostino H, et al.
Thorac Cancer
. 2017 Sep;
3(2):169-174.
PMID: 28920295
Objectives: Evaluate the dosimetric impact of selective/elective nodal treatment with dose-escalated radiotherapy for regionally advanced non-small-cell lung cancer (NSCLC) using proton therapy (PT) or intensity-modulated radiotherapy (IMRT). Methods: Five consecutive...
8.
Nichols Jr R, Henderson R, Huh S, Flampouri S, Li Z, Bajwa A, et al.
Thorac Cancer
. 2017 Sep;
3(2):109-116.
PMID: 28920285
Proton therapy is an emerging radiotherapy technology with the potential to improve the therapeutic index in the treatment of lung cancer patients. Since charged particles, such as protons, have a...
9.
Shi W, Nichols Jr R, Flampouri S, Li Z, Hsi W, Huh S, et al.
Thorac Cancer
. 2017 Sep;
4(2):198-202.
PMID: 28920189
In this case report, we present the history and treatment of a 70-year-old man with synchronous bilateral non-small-cell lung cancers with proton-beam radiation. Surgical treatment was not feasible and optimized...
10.
Hoppe B, Henderson R, Pham D, Cury J, Bajwa A, Morris C, et al.
Int J Radiat Oncol Biol Phys
. 2016 Jan;
95(1):517-522.
PMID: 26774428
Purpose: Proton therapy has been shown to reduce radiation dose to organs at risk (OAR) and could be used to safely escalate the radiation dose. We analyzed outcomes in a...